[SaneVax: Despite decades of vaccinations aimed at preventing whooping cough, there were more reported cases during 2012 in the United States than before the vaccine was invented. The CDC’s answer is more booster shots. Will this solve the problem, or further exacerbate the issue?]
Pertussis outbreak sparks debate over effectiveness of the vaccine
By Jennifer Cruz
2012 was a record year for whooping cough cases. On Sunday, Jan. 6, ABC News 23 stated that approximately 42,000 cases of whooping cough, also known as pertussis, were reported last year. This has been the largest outbreak of pertussis since 1955. The sudden spike in the condition has left many unanswered questions about the disease itself and, more importantly, the effectiveness of the vaccine.
The pertussis vaccine is given in three separate doses at ages two, four and six months and boosters again at 15-18 months, 4-6 years, 10 years and again as an adult, for a total of at least seven doses. It is given in a shot containing the vaccines for diphtheria, tetanus, and pertussis, known as DTaP.
According to Dr. Anne Schuchat, director for the National Center for Immunization and Respiratory Diseases at the Center for Disease Control, stated that about half of the cases involved infants under the age of 3 months, but yet the first dose is given at two months. She then argues that the high number of cases in infants is due to the fact that at that young age the vaccine doesn’t yet work properly.
Read the entire article here.